The low-FODMAP diet.
Study Goal
The researchers aimed to present a protocol for the low-FODMAP diet in paediatric patients and review current evidence on its efficacy for managing gastrointestinal disorders.
Results Summary
The study found that the low-FODMAP diet reduces symptoms, particularly in paediatric patients with functional gastrointestinal disorders, and outlines a structured three-phase approach (elimination, reintroduction, personalization). However, more research is needed to confirm its benefits in this population.
Population
Paediatric patients with gastrointestinal disorders, particularly irritable bowel syndrome.
Effective Dosage
Not specified (dietary protocol involves elimination for 2-3 weeks, reintroduction over 8 weeks, and personalization).
Duration
Elimination phase: 2-3 weeks; reintroduction phase: 8 weeks; personalization phase: duration not specified.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low-FODMAP diet | decrease | symptoms | paediatric age group | - | beneficial effects | #1 |
low-FODMAP diet | decrease | symptoms | patients with functional gastrointestinal disorders | - | reduction | #2 |
In this article we present a protocol for the use of the low-FODMAP diet in paediatric patients and review of the current evidence on its efficacy. These short-chain carbohydrates, which can be fermented by the intestinal microbiota, are found in a wide variety of foods, mainly of plant origin. The low-FODMAP diet is a therapeutic tool used for the management of gastrointestinal disorders such as irritable bowel syndrome. The sources we used were PubMed, Web of Science, Google Scholar and institutional websites. Following consumption of FODMAP-rich foods, a series of end products are generated that are not absorbed, giving rise to symptoms. Before starting a low-FODMAP diet, it is important to carry out a diagnostic evaluation including any applicable tests. Treatment is structured in 3 phases: elimination, reintroduction and personalization phase. In the first phase, FODMAP-rich foods are eliminated for 2-3 weeks. In the second phase, lasting 8 weeks, FODMAP-rich foods are gradually reintroduced. The last phase consists in customizing the diet according to individual tolerance. This article details which foods contain FODMAPs and possible substitutes. In addition, specific food diary/intake tracking and educational materials are provided in a series of appendices to facilitate adherence to the diet. Although most studies have been conducted in adults, there is also some evidence on the beneficial effects in the paediatric age group, with a reduction of symptoms, especially in patients with functional gastrointestinal disorders. Nevertheless, more research is required on the subject.